Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 45601-45650 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05797857
Exercise Training in Transthyretin Cardiac Amyloidosis
NARecruiting
40 participants
Started: Jul 10, 2024 · Completed: Jun 30, 2030
2 conditions1 sponsor1 location
NCT06504901
Evaluation of Efficacy and Safety of PD-1 Monoclonal Antibody in Combination With rhG-CSF, IL-2, and CapeOX in Initially Resectable Synchronous Colorectal Liver Metastases
N/ANot yet recruiting
30 participants
Started: Jul 10, 2024 · Completed: Jul 10, 2027
1 condition1 sponsor0 locations
NCT06525662
Stylet Shape in Simulated Endotracheal Intubation by Medical Students
NARecruiting
268 participants
Started: Jul 10, 2024 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT04921865
Case Series on the Clinical Performance of VA Clavicle and Clavicle Hook Plate 2.7 Systems
N/ARecruiting
76 participants
Started: Jul 10, 2024 · Completed: Sep 30, 2029
3 conditions1 sponsor7 locations
NCT06548958
A Single-Arm, Prospective Study of TBI+BUMEL as Conditioning for SCT2 in Patients With Malignant Hematologic Diseases
NARecruiting
40 participants
Started: Jul 10, 2024 · Completed: Jun 30, 2027
1 condition1 sponsor1 location
NCT06250179
3D VOLUMETRIC CHANGE OF THE PALATAL DONOR REGION IN WOUND HEALING
NAActive, not recruiting
45 participants
Started: Jul 10, 2024 · Completed: Dec 1, 2024
1 condition2 sponsors1 location
NCT06442449
Booster Dose of sIPV Co-administered With MMR and HepA-I.
PHASE4Not yet recruiting
960 participants
Started: Jul 10, 2024 · Completed: Mar 10, 2025
1 condition1 sponsor1 location
NCT06315322
A Study to Test the Long-term Safety and Tolerability of Brivaracetam in Study Participants With Childhood Absence Epilepsy or Juvenile Absence Epilepsy
PHASE3Recruiting
120 participants
Started: Jul 10, 2024 · Completed: Mar 1, 2030
2 conditions1 sponsor23 locations
NCT06550128
Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB).
PHASE2Active, not recruiting
86 participants
Started: Jul 10, 2024 · Completed: Jun 30, 2026
1 condition1 sponsor6 locations
NCT06568770
Comparison of EOSP Between Usg Guided S-FICB vs USG Guided PENG Block in Pts Undergoing Femur Fracture Surgery
PHASE2/PHASE3Recruiting
70 participants
Started: Jul 10, 2024 · Completed: Jan 10, 2026
4 conditions1 sponsor1 location
NCT06569368
Trial Utilizing Metronidazole to Optimize the Microbiome of Rectal Adenocarcinoma Undergoing Neoadjuvant Therapy
PHASE2Recruiting
60 participants
Started: Jul 10, 2024 · Completed: Oct 31, 2028
1 condition1 sponsor1 location
NCT06776692
Characterisation of Dengue Vaccine-induced Specific Immunity in Vaccinees With and Without Prior Exposure to Flavivirus Infections or Vaccination
N/ARecruiting
402 participants
Started: Jul 10, 2024 · Completed: Jan 31, 2028
1 condition1 sponsor1 location
NCT06185686
Radiation Induced Alterations in Resting State Brain Networks in Pediatric Brain Tumor Patients
N/ARecruiting
16 participants
Started: Jul 10, 2024 · Completed: Jul 31, 2027
1 condition4 sponsors1 location
NCT06583811
Remifentanil and Remimazolam to Limit Patient Movement
NARecruiting
70 participants
Started: Jul 10, 2024 · Completed: Jan 10, 2025
1 condition2 sponsors1 location
NCT06912997
Effects of Inspiratory Muscle Training on Parkinson's Disease
NAActive, not recruiting
30 participants
Started: Jul 10, 2024 · Completed: Jan 31, 2026
1 condition1 sponsor1 location
NCT06398158
Study of the Clinical and Radiological Impact of Ravulizumab in People With Neuromyelitis Optica Spectrum Disorder
N/ARecruiting
35 participants
Started: Jul 10, 2024 · Completed: Jun 30, 2027
1 condition2 sponsors1 location
NCT06505486
GEMOX-HAIC Plus GEM-SYS in Combination With Lenvatinib and PD-1 Inhibitor for Large Unresectable ICC
N/ARecruiting
21 participants
Started: Jul 10, 2024 · Completed: Jul 10, 2025
1 condition1 sponsor1 location
NCT06756152
Preventing of GVHD with Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Ruxolitinib At Children and Young Adults with Hemoblastosis
PHASE2/PHASE3Recruiting
50 participants
Started: Jul 10, 2024 · Completed: Oct 10, 2026
6 conditions1 sponsor1 location
NCT06254014
A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Placebo in T2DM Patients
PHASE3Active, not recruiting
270 participants
Started: Jul 10, 2024 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT06875453
De Tethering Exercises for Scolisis
NAActive, not recruiting
15 participants
Started: Jul 10, 2024 · Completed: Sep 30, 2025
3 conditions1 sponsor1 location
NCT06827938
Multicenter Real-World Study of Hyperthermia in Warts of Special Population
NARecruiting
400 participants
Started: Jul 10, 2024 · Completed: Jul 10, 2027
1 condition1 sponsor1 location
NCT06453291
Assessment of Different Clinical Techniques to Treat Patients With Chronic Low Back Pain
NARecruiting
100 participants
Started: Jul 10, 2024 · Completed: May 31, 2025
1 condition1 sponsor1 location
NCT06487702
A Phase lb/lI Clinical Study in Advanced or Metastatic Esophageal Squamous Cell Carcinoma
PHASE2Not yet recruiting
70 participants
Started: Jul 10, 2024 · Completed: Jun 10, 2027
1 condition1 sponsor1 location
NCT06506929
Task Specific Training for Advanced Multiple Sclerosis
NARecruiting
15 participants
Started: Jul 10, 2024 · Completed: Jan 31, 2026
1 condition2 sponsors1 location
NCT06497179
Effect of Handedness on Electromyographic Activity of Hand Muscles and Nerve Conduction Velocity During Use Mobil Phone in School Age Children
N/AActive, not recruiting
70 participants
Started: Jul 10, 2024 · Completed: Sep 10, 2024
1 condition1 sponsor1 location
NCT06482021
Comparative Effectiveness Of Low Extra-Corporeal Shock Wave Versus Acetylcholine Iontophoresis On Type2 Diabetic Neuropathy
NANot yet recruiting
80 participants
Started: Jul 10, 2024 · Completed: Oct 1, 2024
1 condition1 sponsor0 locations
NCT05907759
Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease
PHASE2Recruiting
28 participants
Started: Jul 10, 2024 · Completed: Dec 1, 2035
1 condition1 sponsor1 location
NCT06511622
Impact of Immune Status on Secondary Infections in Patients With Acute Respiratory Failure
N/ARecruiting
200 participants
Started: Jul 10, 2024 · Completed: May 22, 2025
1 condition1 sponsor1 location
NCT05923606
Modulation of Brain Oscillations Underlying Working Memory
NARecruiting
32 participants
Started: Jul 10, 2024 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT06485830
Neural Mobilization and Cerebral Palsy
NARecruiting
42 participants
Started: Jul 10, 2024 · Completed: Jun 15, 2025
2 conditions2 sponsors2 locations
NCT06552286
STRW-T Intervention for Autistic Adolescents in 11th and 12th Grade
NARecruiting
192 participants
Started: Jul 10, 2024 · Completed: Dec 31, 2029
1 condition3 sponsors2 locations
NCT06290557
First-in-man Single-dose and Multiple Dose Study to Evaluate the Safety, Tolerability and Efficacy ofHY-133
PHASE1Recruiting
52 participants
Started: Jul 10, 2024 · Completed: Jul 1, 2026
1 condition1 sponsor2 locations
NCT06590818
The Effect of Body Mass Index on Short-term Results of HTO
NARecruiting
50 participants
Started: Jul 10, 2024 · Completed: Jul 10, 2025
2 conditions2 sponsors1 location
NCT06519474
Effect of Elastic Chest Compression on Functional Exercise Capacity and Respiratory Performance in Patients With COPD
NARecruiting
17 participants
Started: Jul 10, 2024 · Completed: May 31, 2027
2 conditions1 sponsor1 location
NCT06586840
The Effect of Adding an IPACK Block to the Adductor Canal Block on Total Knee Arthroplasty Surgery
N/ARecruiting
80 participants
Started: Jul 10, 2024 · Completed: Apr 1, 2025
1 condition1 sponsor1 location
NCT06211361
Cardiac Rehabilitation Program in Patients with Cardiovascular Disease
NAActive, not recruiting
80 participants
Started: Jul 10, 2024 · Completed: Oct 30, 2024
1 condition2 sponsors1 location
NCT06630624
Dose Finding, Efficacy and Immunological Response of IP-001 Following MWA or IRE for CRLM
PHASE1/PHASE2Recruiting
120 participants
Started: Jul 10, 2024 · Completed: Aug 1, 2031
3 conditions3 sponsors1 location
NCT06503302
The Effect of Doppler Ultrasound on Calcified Tendinitis
NARecruiting
100 participants
Started: Jul 10, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT07075614
The Effectiveness of a Parent Training Program for Children With Autism Spectrum Disorder and High-Risk Infants: A Case-Control Study
NAEnrolling by invitation
250 participants
Started: Jul 10, 2024 · Completed: Mar 31, 2026
1 condition2 sponsors1 location
NCT06392009
Astroscape: A Study of Radiprodil on Safety, Tolerability, Pharmacokinetics, and Effect on Seizures and Behavioral Symptoms in Patients With TSC or FCD Type II
PHASE1/PHASE2Recruiting
30 participants
Started: Jul 10, 2024 · Completed: Jul 31, 2026
2 conditions1 sponsor20 locations
NCT06486337
CMOP±R in the Treatment of Untreated Non-Hodgkin's Lymphoma
PHASE2Not yet recruiting
197 participants
Started: Jul 10, 2024 · Completed: Aug 31, 2027
1 condition1 sponsor0 locations
NCT06093100
Wearable Technology to Evaluate Hyperglycemia and HRV in DMD - Longitudinal Aim
N/ARecruiting
10 participants
Started: Jul 10, 2024 · Completed: Dec 31, 2030
1 condition1 sponsor1 location
NCT06423274
Comparing Artificial Intelligence for Assisted Diagnosis of Diabetic Retinopathy
N/ANot yet recruiting
1,000 participants
Started: Jul 10, 2024 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05602649
The Impact of Product Formulation on the Pharmacokinetics and Pharmacodynamics of Cannabis Edibles
PHASE1Recruiting
80 participants
Started: Jul 10, 2024 · Completed: Jan 31, 2027
1 condition2 sponsors1 location
NCT06373679
Switch or Quit R01
NARecruiting
225 participants
Started: Jul 10, 2024 · Completed: May 1, 2027
2 conditions2 sponsors1 location
NCT06541509
Mechanisms of Semaglutide Therapy in Heart Failure Patients
PHASE1/PHASE2Recruiting
10 participants
Started: Jul 10, 2024 · Completed: Sep 1, 2025
2 conditions3 sponsors3 locations
NCT06471738
Combination of Zanubrutinib, Rituximab and Venetoclax in Patients With Previously Untreated Follicular Lymphoma
PHASE2Recruiting
30 participants
Started: Jul 10, 2024 · Completed: Jun 1, 2027
6 conditions1 sponsor1 location
NCT06650332
Cadonilimab Combination Regimen as First-line Treatment for HER2-expressing GC/GEJ Patients
PHASE1/PHASE2Recruiting
90 participants
Started: Jul 10, 2024 · Completed: Dec 30, 2027
1 condition1 sponsor1 location
NCT06387628
LM-108 in Combination With PD-1 Based Treatment for Patients With Recurrent or Metastatic Triple - Negative Breast Cancer
PHASE2Recruiting
74 participants
Started: Jul 10, 2024 · Completed: Apr 1, 2027
1 condition1 sponsor1 location
NCT06669962
Characterisation of the Biochemical Profile and Physiology of the Coronary Circulation in Takotsubo Syndrome
N/ARecruiting
50 participants
Started: Jul 10, 2024 · Completed: Jun 27, 2027
1 condition1 sponsor1 location